Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,768 | 15,798 | 11,700 | 8,026 | 11,026 |
| Marketable Securities | 1,725 | 2,548 | 26,251 | 35,413 | 37,243 |
| Receivables | 1,939 | 97 | 362 | 525 | 663 |
| Inventories | 341 | 290 | N/A | N/A | N/A |
| TOTAL | $27,550 | $22,637 | $48,366 | $54,450 | $58,034 |
| Non-Current Assets | |||||
| PPE Net | 5,336 | 6,025 | 6,106 | 6,478 | 6,974 |
| Intangibles | 32,852 | 33,021 | 18,250 | 18,342 | 18,539 |
| Other Non-Current Assets | 12,898 | 11,830 | 12,231 | 10,311 | 10,808 |
| TOTAL | $51,086 | $50,876 | $36,587 | $35,131 | $36,321 |
| Total Assets | $78,636 | $73,513 | $84,953 | $89,581 | $94,355 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 11,545 | 20,837 | 57,595 | 57,879 | 2,576 |
| Accounts payable and accrued liabilities | 7,558 | 6,595 | 1,299 | 1,035 | 973 |
| Accrued Expenses | 28,762 | 26,034 | 23,308 | 16,883 | 30,167 |
| TOTAL | $47,945 | $53,546 | $82,282 | $75,877 | $33,796 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,700 | 9,879 | 3,921 | 4,155 | 4,242 |
| Deferred Revenues | 80 | 80 | 80 | 80 | 80 |
| Other Non-Current Liabilities | 134,838 | 117,579 | 94,380 | 94,120 | 156,943 |
| TOTAL | $144,884 | $127,856 | $98,719 | $98,713 | $161,643 |
| Total Liabilities | $192,829 | $181,402 | $181,001 | $174,590 | $195,439 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 39 | 32 | 17 | 17 | 14 |
| Common Shares | 1,040,975 | 979,295 | 954,015 | 917,301 | 884,300 |
| Retained earnings | -1,164,017 | -1,109,413 | -1,070,351 | -1,017,748 | -989,847 |
| Other shareholders' equity | 8,849 | 22,229 | 20,288 | 15,438 | 4,463 |
| TOTAL | $-114,193 | $-107,889 | $-96,048 | $-85,009 | $-101,084 |
| Total Liabilities And Equity | $78,636 | $73,513 | $84,953 | $89,581 | $94,355 |